Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...

The Influenza A H3N2 virus subclade K represents a change in the basic structure of the influenza virus. One of the first ...

Researchers are edging closer to a universal antiviral drug, a single medicine that could treat every virus known to man.

Reading recalls the subclade-K variant emerged towards the end of Australia and New Zealand's typical flu season, circulating ...

Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...

Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Early estimates cited by the World Health Organization suggest that seasonal influenza vaccines continue to protect against severe illness and hospitalization in both children and adults. iStock A new ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

It was estimated that QIVc prevented 636,209 more symptomatic influenza cases than QIVe among individuals in the US aged 6 months to 64 years. Cell-based quadrivalent influenza vaccine (QIVc) was ...

A new version of the common flu is spreading globally, and health officials are monitoring this evolving strain of influenza A(H3N3) Subclade K, which has been increasingly detected worldwide.